戻る
Minerva Neurosciences Inc (NERV)価格
NERV 株価推移チャート
NERV 収入
Minerva Neurosciences Inc
$4.48
0.67%
$0.03
本日現在の状況：Jan 20, 14:49:16 GMT-5
主要データ
前終値
$4.45
始値
$4.37
当日レンジ
$4.25 - $4.55
52週レンジ
$1.15 - $12.46
取引高
33.6K
平均取引高
2.1M
1株当たり利益(TTM)
-1.85
配当利回り
--
時価総額
$31.3M
NERVとは何ですか？
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The company is headquartered in Waltham, Massachusetts and currently employs 8 full-time employees. The company went IPO on 2014-06-25. The firm is involved in developing roluperidone for the treatment of negative symptoms in patients with schizophrenia and has exclusive rights to develop and commercialize MIN-301 for the treatment of Parkinson’s disease. The company has also co-developed seltorexant for the treatment of insomnia disorder and adjunctive treatment of major depressive disorder (MDD). Seltorexant is an innovative selective orexin 2 receptor antagonist. Its Roluperidone is a compound that has been shown to block serotonin, sigma, and α-adrenergic receptors that are involved in the regulation of mood, cognition, sleep and anxiety. Roluperidone has been designed to block a specific subtype of serotonin receptor called 5-HT2A.